Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice

// Marianna L. Ianzano 1,* , Stefania Croci 1,3,* , Giordano Nicoletti 2,* , Arianna Palladini 1 , Lorena Landuzzi 2 , Valentina Grosso 1 , Dario Ranieri 1 , Massimiliano Dall’Ora 1 , Ilaria Santeramo 1 , Milena Urbini 1 , Carla De Giovanni 1 , Pier-Luigi Lollini 1 and Patrizia Nanni 1 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna. 2 Laboratory of Experimental Oncology, “Rizzoli” Orthopedic Institute, Bologna, Italy. 3 Present address: Clinical Immunology, Allergy and Advanced Bio-technologies Unit, IRCCS – Arcispedale Santa Maria Nuova, Reggio Emilia, Italy. * These authors contributed equally to the work Correspondence: Pier-Luigi Lollini, email: // Keywords : rhabdomyosarcoma, p53, HER-2, p19Arf, p21Cip1 Received : July 23, 2013 Accepted : August 4, 2013 Published : August 6, 2013 Abstract Human sarcomas arise suddenly, thus preempting the study of preneoplastic and early neoplastic lesions. To explore the natural history of these tumors we studied male mice carrying a heterozygous deletion of p53 and an activated HER-2/neu transgene (BALB-p53Neu mice), that develop urethral rhabdomyosarcomas with nearly full penetrance and early onset (4 months of age). Among genes prominently upregulated in preneoplastic tissue, and more highly expressed in tumors, we found the insulin - like growth factor 2 ( Igf2 ) and tumor suppressors, p19Arf and p21Cip1 . In urethral tissues of male mice p53 was less expressed than in female mice, whereas HER-2/neu was more expressed, a combination not found in other skeletal muscles of the same mice that could contribute to the anatomic and sexual specificity of BALB-p53Neu rhabdomyosarcoma. Upregulation of p19Arf and p21Cip1 was additively determined by HER-2/neu activation and by p53 inactivation. Silencing of p19Arf or p21Cip1 in rhabdomyosarcoma cell lines can inhibit cell growth and motility, thus suggesting that these genes can contribute to growth autonomy and malignancy of tumor cells. In vivo injection of gene-silenced cells highlighted selective variations in organ-specific metastatic ability, indicating that overexpression of p19Arf and p21Cip1 controlled both tumor cell-intrinsic properties and microenvironmental interactions. The onset of pelvic rhabdomyosarcoma in BALB-p53Neu male mice is triggered by the coincidental overexpression of HER-2/neu and hypoexpression of the residual p53 allele, that foster p53 loss, Igf2 autocriny and overexpression of p19Arf and p21Cip1 , a phenotype that could provide novel potential targets for cancer prevention and therapy.